- Home
- DV vs ATAI Comparison
DV vs ATAI Comparison
Compare DV & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DV | ATAI |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DV | ATAI |
|---|---|---|
| Price | $10.73 | $3.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 7 |
| Target Price | ★ $16.18 | $15.57 |
| AVG Volume (30 Days) | 3.0M | ★ 4.2M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $748,291,000.00 | $308,000.00 |
| Revenue This Year | $13.59 | N/A |
| Revenue Next Year | $9.91 | $285.00 |
| P/E Ratio | $36.58 | ★ N/A |
| Revenue Growth | ★ 13.92 | N/A |
| 52 Week Low | $7.61 | $1.15 |
| 52 Week High | $16.82 | $6.73 |
Technical Indicators
Market Signals| Indicator | DV | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 47.46 |
| Support Level | $10.49 | $3.42 |
| Resistance Level | $11.51 | $4.40 |
| Average True Range (ATR) | 0.48 | 0.27 |
| MACD | 0.20 | -0.03 |
| Stochastic Oscillator | 87.29 | 30.73 |
Price Performance
Historical ComparisonAbout DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.